CHARLOTTESVILLE, Va., – A dermatologist formerly employed at a dermatological practice in the City of Charlottesville was sentenced last week to 12 months probation, including a period of home confinement and electronic monitoring, for using the Drug Enforcement Administration (DEA) registration number of her co-workers to obtain prescription opioid pain...

ABINGDON, Va., – A Dobson, North Carolina man pleaded guilty yesterday to conspiring to distribute medically illegitimate prescriptions for Schedule II opioids and Suboxone, as well as conspiring to use, in the course of the distribution of controlled substances, the DEA registration number of another person. According to court documents...

Greenbelt, Maryland – U.S. District Judge Paula Xinis sentenced Ana Christina Avalos a/k/a “Christina Cazares-Quintero”, age 35, of Phelan, California, to 57 months in federal prison, followed by five years of supervised release for conspiracy to distribute and possession with intent to distribute controlled substances. The sentence was announced by...

Baltimore, Md., – U.S. District Judge Ellen L. Hollander sentenced Derek Crosby, age 40, of Baltimore, yesterday to 102 months in federal prison, followed by four years of supervised release for conspiracy to distribute fentanyl, heroin, cocaine, and crack cocaine in the Monument Street area of East Baltimore, and for...

NEW YORK – The United States Attorney for the Southern District of New York, Geoffrey S. Berman, the Drug Enforcement Administration Special Agent in Charge of the New York Division, Raymond P. Donovan, Special Agent in Charge of the New York Office of Homeland Security Investigations, Peter C. Fitzhugh, Superintendent...

SACRAMENTO, Calif. — A Rancho Cordova woman was indicted on April 4, 2019, charged with distribution of fentanyl and oxycodone and other opioids as a result of a coordinated operation by the U.S. Attorney’s Office, the Federal Bureau of Investigation, Homeland Security Investigations, the Drug Enforcement Administration and the U.S...

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...